Analyst Ratings for Ironwood Pharmaceuticals (IRWD) [Sells]

IRWD Rating Summary

IRWD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IRWD
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $13.70 (-0.8%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
11/6/2014 Cantor Fitzgerald Downgrade Sell
(Hold)
10.00
(11.00)
12.59 13.81 9.69% Details
9/17/2013 Goldman Sachs New Coverage Sell
(N/A)
9.50
(N/A)
13.64 13.81 1.25% Details
Like IRWD Ratings? Also take a look at SGYP, ACT, FRX, SLXP

IRWD Ratings News